July 21, 2008
Genentech Goes Roche?
South San Francisco biotechnology company Genentech, makers of some of the world's most boring prescription drugs ever (e.g., supplementary growth hormones Protropin and Nutropin, clot-busting pill TNKase, non-Hodgkins lymphomas treatment Rituxan, and zzzzzzz) might be bought out by Swiss drug company Roche. The European pill-pushers are offering the Bay Area company a whopping $43.7 billion. Genentech, though, is expected "to refuse the bid and strive to remain independent." Or, most likely, turn this offer down and strive to get a higher one.
| 
add to stumble upon
add to reddit
email this
add to facebook
add to del.icio.usAdvertisement: SFist Continues Below!
Post a comment (Comment Policy)
What about Avastin and Herceptin? I guess that breast and colorectal cancer are too "boring" to mention.
can you crush and snort them for fun? if so, i stand corrected.
"The ones mother gives you do nothing at all..."
I didn't know they invented Rituxan. I had to be injected with it several times last year. Until that point, I'd never spent so much money on a drug which made me feel so unbelievably crappy. But the stuff worked.
Oh noes! Oh wait. I don't even care. Last week the Gav spoke to my conventioneering group about how safe for business he'd made the city principally as it concerns biotech and green tech... I hope the jobs don't leave. I work in a nonprofit and when company bosses are overseas, they obvs care less about the communities they do business in...
roche is the industry standard in fun stuff
roche is also the industry standard in evil.